Companies / Atrium Therapeutics, Inc. / Activity
Activity — Atrium Therapeutics, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Skerjanec Simona Director | Grant | Stock Option (Right to Buy) | — | +20K | 20,000 0.12% of shares | low |
| Feb 27, 2026 | Flanagan W. Michael Director | Grant | Stock Option (Right to Buy) | — | +20K | 20,000 0.12% of shares | low |
| Feb 27, 2026 | Boyce Sarah Director | Grant | Stock Option (Right to Buy) | — | +20K | 20,000 0.12% of shares | low |
| Feb 27, 2026 | Wilson Troy Edward Director | Grant | Stock Option (Right to Buy) | — | +20K | 20,000 0.12% of shares | low |
| Feb 27, 2026 | Boess Carsten Director | Grant | Stock Option (Right to Buy) | — | +20K | 20,000 0.12% of shares | low |